litlas
Log inCreate account

Pierre Miossec

Active 1984–2025

101
Papers
19,136
Citations
75
h-index
98
i10-index

Citations

Citations per year for Pierre Miossec1985: 3 citations1986: 4 citations1987: 6 citations1988: 14 citations1989: 6 citations1990: 14 citations1991: 7 citations1992: 7 citations1993: 18 citations1994: 20 citations1995: 25 citations1996: 44 citations1997: 44 citations1998: 63 citations1999: 63 citations2000: 102 citations2001: 119 citations2002: 111 citations2003: 128 citations2004: 111 citations2005: 113 citations2006: 82 citations2007: 138 citations2008: 163 citations2009: 199 citations2010: 191 citations2011: 194 citations2012: 183 citations2013: 194 citations2014: 196 citations2015: 210 citations2016: 147 citations2017: 220 citations2018: 149 citations2019: 602 citations2020: 617 citations2021: 697 citations2022: 509 citations2023: 375 citations2024: 557 citations2025: 266 citations2026: 4 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,672 citing papers, 21.1% of this breakdownChina: 1,355 citing papers, 17.1% of this breakdownUnited Kingdom: 525 citing papers, 6.6% of this breakdownGermany: 408 citing papers, 5.1% of this breakdownFrance: 364 citing papers, 4.6% of this breakdownItaly: 307 citing papers, 3.9% of this breakdownJapan: 297 citing papers, 3.7% of this breakdownNetherlands: 284 citing papers, 3.6% of this breakdownCanada: 218 citing papers, 2.7% of this breakdownSouth Korea: 167 citing papers, 2.1% of this breakdownSwitzerland: 158 citing papers, 2% of this breakdownAustralia: 147 citing papers, 1.9% of this breakdown
0%21.1%Other 25.6%

Institutions

Fields

  • Medicine48.7%
  • Immunology and Microbiology26.3%
  • Biochemistry, Genetics and Molecular Biology15%
  • Nursing2.7%
  • Neuroscience1.7%
  • Dentistry1.7%
  • Other3.9%

Topics

  • Psoriasis: Treatment and Pathogenesis6.6%
  • Rheumatoid Arthritis Research and Therapies6.2%
  • T-cell and B-cell Immunology3.8%
  • Spondyloarthritis Studies and Treatments2.9%
  • Immune Cell Function and Interaction2.7%
  • Cytokine Signaling Pathways and Interactions2.7%
  • Other75.1%

Coauthors

All papers

Open in search
  1. Targeting IL-17 and TH17 cells in chronic inflammation

    Authors: Pierre Miossec, Jay K. Kolls - Nature Reviews Drug Discovery 2012 cited by 1,389

  2. Th17 and regulatory T cell balance in autoimmune and inflammatory diseases

    Authors: Mélissa Noack, Pierre Miossec - Autoimmunity Reviews 2014 cited by 928

  3. Zinc and its role in immunity and inflammation

    Authors: Paola Bonaventura, Giulia Benedetti, Francis Albarède, Pierre Miossec - Autoimmunity Reviews 2014 cited by 795

  4. Th17 Cells

    Authors: Mohan S. Maddur, Pierre Miossec, Srini V. Kaveri, Jagadeesh Bayry - American Journal Of Pathology 2012 cited by 613

  5. Gut microbiota and osteoarthritis management: An expert consensus of the European society for clinical and economic aspects of osteoporosis, osteoarthritis and musculoskeletal diseases (ESCEO)

    Authors: Emmanuel Biver, Françis Berenbaum, Ana M. Valdes, Islène Araujo de Carvalho, Laure B. Bindels, Maria Luisa Brandi, Philip C. Calder, Vincenzo Castronovo, Etienne Cavalier, Antonio Cherubini, Cyrus Cooper, Elaine Dennison, Claudio Franceschi, Nicholas R. Fuggle, Andrea Laslop, Pierre Miossec, Thierry Thomas, Şansın Tüzün, Nicola Veronese, Mila Vlaskovska, Jean‐Yves Reginster, René Rizzoli - Ageing Research Reviews 2019 cited by 185

  6. Classical and Paradoxical Effects of TNF-α on Bone Homeostasis

    Authors: Bilal Osta, Giulia Benedetti, Pierre Miossec - Frontiers in Immunology 2014 cited by 384

  7. Dual IL-17A and IL-17F neutralisation by bimekizumab in psoriatic arthritis: evidence from preclinical experiments and a randomised placebo-controlled clinical trial that IL-17F contributes to human chronic tissue inflammation

    Authors: Sophie Glatt, Dominique Baeten, Terry Baker, Meryn Griffiths, Lucian Ionescu, Alastair D. G. Lawson, Ash Maroof, Ruth Oliver, Serghei Popa, Foteini Strimenopoulou, Pavan Vajjah, Mark Watling, Nataliya Yeremenko, Pierre Miossec, Stevan Shaw - Annals of the Rheumatic Diseases 2017 cited by 259

  8. Interleukin-17 and Type 17 Helper T Cells

    Authors: Pierre Miossec, Thomas Korn, Vijay K. Kuchroo - New England Journal of Medicine 2009 cited by 1,396

  9. Systemic effects of IL-17 in inflammatory arthritis

    Authors: Audrey Beringer, Pierre Miossec - Nature Reviews Rheumatology 2019 cited by 160

  10. Selected cytokine pathways in rheumatoid arthritis

    Authors: Mélissa Noack, Pierre Miossec - Seminars in Immunopathology 2017 cited by 310

  11. IL-17 in Chronic Inflammation: From Discovery to Targeting

    Authors: Audrey Beringer, Mélissa Noack, Pierre Miossec - Trends in Molecular Medicine 2016 cited by 400

  12. IL-17 in Rheumatoid Arthritis and Precision Medicine: From Synovitis Expression to Circulating Bioactive Levels

    Authors: Marie Robert, Pierre Miossec - Frontiers in Medicine 2019 cited by 166

  13. Effects of Interleukin 17 on the cardiovascular system

    Authors: Marie Robert, Pierre Miossec - Autoimmunity Reviews 2017 cited by 148

  14. Brief Report: Inhibition of interleukin‐6 function corrects Th17/Treg cell imbalance in patients with rheumatoid arthritis

    Authors: M. Samson, Sylvain Audia, Nona Janikashvili, Marion Ciudad, Malika Trad, Jennifer Fraszczak, Paul Ornetti, Jean-Françis Maillefert, Pierre Miossec, Bernard Bonnotte - Arthritis & Rheumatism 2012 cited by 345

  15. The IL-23–IL-17 pathway as a therapeutic target in axial spondyloarthritis

    Authors: Joachim Sieper, Denis Poddubnyy, Pierre Miossec - Nature Reviews Rheumatology 2019 cited by 141

  16. Altered dendritic cell functions in autoimmune diseases: distinct and overlapping profiles

    Authors: Frédéric Coutant, Pierre Miossec - Nature Reviews Rheumatology 2016 cited by 122

  17. Effects of interleukin (IL)-17A and IL-17F in human rheumatoid arthritis synoviocytes

    Authors: A. Hot, Pierre Miossec - Annals of the Rheumatic Diseases 2011 cited by 208

  18. Human interleukin-17: A T cell-derived proinflammatory cytokine produced by the rheumatoid synovium

    Authors: Martine Chabaud, Jean Marc Durand, Nicolas C. Buchs, Fran�ois Fossiez, Guillaume Page, Lucien Frappart, Pierre Miossec - Arthritis & Rheumatism 1999 cited by 943

  19. Evolving concepts of the pathogenesis of rheumatoid arthritis with focus on the early and late stages

    Authors: Frédéric Coutant, Pierre Miossec - Current Opinion in Rheumatology 2019 cited by 111

  20. IgM rheumatoid factor amplifies the inflammatory response of macrophages induced by the rheumatoid arthritis-specific immune complexes containing anticitrullinated protein antibodies

    Authors: Lætitia Laurent, Florence Anquetil, C Clavel, Ndiémé Ndongo-Thiam, Géraldine Offer, Pierre Miossec, Jean‐Louis Pasquali, Mireille Sebbag, Guy Serre - Annals of the Rheumatic Diseases 2014 cited by 127

  21. The Th17 Pathway in Vascular Inflammation: Culprit or Consort?

    Authors: Marie Robert, Pierre Miossec, A. Hot - Frontiers in Immunology 2022 cited by 40

  22. IL-17 as a future therapeutic target for rheumatoid arthritis

    Authors: Wim B. van den Berg, Pierre Miossec - Nature Reviews Rheumatology 2009 cited by 315

  23. Immunosuppressive properties of methotrexate: apoptosis and clonal deletion of activated peripheral T cells.

    Authors: Laurent Genestier, Romain Paillot, Sylvie Fournel, Carole Ferraro, Pierre Miossec, J.P. Revillard - Journal of Clinical Investigation 1998 cited by 464

  24. IL-17 and IL-17-producing cells and liver diseases, with focus on autoimmune liver diseases

    Authors: Audrey Beringer, Pierre Miossec - Autoimmunity Reviews 2018 cited by 92